For the quarter ending 2026-03-31, BTSG had $800,320K increase in cash & cash equivalents over the period. $101,399K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Impairment of long-lived assets | - | 6,102 | 2,507 | 4,019 |
| Change in fair value of contingent consideration, net | - | 0 | -3,269 | 2,003 |
| Loss on disposition of fixed assets | - | -573 | -342 | -1,161 |
| Net income | 148,610 | 77,320 | 55,241 | 56,552 |
| Payment of contingent consideration in excess of acquisition date fair value | - | 0 | 4,670 | 1,500 |
| Depreciation and amortization | 39,094 | 39,524 | 40,753 | 84,000 |
| Provision for credit losses | 10,559 | 7,504 | 8,065 | 40,658 |
| Amortization of deferred debt issuance costs | 2,816 | 2,858 | 2,841 | 5,543 |
| Share-based compensation | 3,676 | 14,366 | 17,250 | 38,483 |
| Deferred income taxes, net | -7,193 | -3,424 | 14,374 | 3,892 |
| Gain on sale of discontinued operations | 103,412 | - | - | - |
| Other | 72 | 2,518 | 416 | 1,422 |
| Accounts receivable | 114,125 | -31,402 | 49,933 | 112,756 |
| Prepaid expenses and other current assets | 7,791 | -5,812 | -446 | -24,411 |
| Inventories | -254,833 | 175,627 | 13,752 | -11,473 |
| Trade accounts payable | -86,987 | 221,335 | -10,441 | 53,277 |
| Accrued expenses | 11,030 | 14,791 | 60,702 | -43,490 |
| Other assets and liabilities | 28,095 | 8,459 | 12,104 | 15,630 |
| Net cash provided by operating activities | 122,943 | 231,559 | 107,936 | 150,674 |
| Purchases of property and equipment | 21,544 | 37,665 | 15,762 | 42,057 |
| Acquisitions of businesses | 42,203 | 196,256 | 1,554 | 6,754 |
| Proceeds from sale of discontinued operations | 810,908 | - | - | - |
| Other | -232 | -37 | 6,445 | -1,377 |
| Net cash provided by (used in) investing activities | 747,393 | -233,884 | -23,761 | -47,434 |
| Long-term debt repayments | 12,353 | 12,342 | 14,213 | 23,720 |
| (repayments) borrowings of the revolving credit facility, net | - | 0 | 0 | -63,300 |
| Repurchase of shares of common stock | 60,000 | 43,173 | - | - |
| Proceeds from shares issued under share-based compensation plan | 12,092 | 10,600 | 5,619 | 9,062 |
| Taxes paid related to net share settlement of equity awards | 5,708 | 1,971 | 1,071 | 4,512 |
| Payment of contingent consideration up to acquisition date fair value | - | 200 | - | - |
| Purchase of redeemable noncontrolling interest | - | 0 | 0 | 5,100 |
| Payments of financing lease obligations | 4,047 | 3,412 | 3,442 | 6,691 |
| Net cash used in financing activities | -70,016 | -50,498 | -13,107 | -94,261 |
| Net increase (decrease) in cash and cash equivalents | 800,320 | -52,823 | 71,068 | 8,979 |
| Cash and cash equivalents at beginning of period | 88,477 | 141,300 | 61,253 | - |
| Cash and cash equivalents at end of period | 888,797 | 88,477 | 141,300 | - |
| Cash and cash equivalents included in continuing operations at end of period | 888,797 | - | - | - |
BrightSpring Health Services, Inc. (BTSG)
BrightSpring Health Services, Inc. (BTSG)